Clinical trial
Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.
NCT07464106 is registered in ClinicalTrials.gov with Robert Bosch Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.
- Lead sponsor
- Robert Bosch Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 1, 2025
- Completion date
- December 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardio-renal syndrome, frailty, tricuspid regurgitation, tricuspid valve insufficiency